• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

REX Shares Announces First ETF for Investing in Corporate Convertible Bonds with Bitcoin

user avatar

by Giorgi Kostiuk

8 months ago


REX Shares announced the launch of an ETF that allows investment in convertible bonds of companies that have Bitcoin in their treasuries.

Launch of REX Shares ETF

REX Shares introduced a new product — REX Bitcoin Corporate Treasury Convertible Bond ETF (BMAX). This fund offers access to convertible bonds issued by companies that already have Bitcoin in their treasuries. Inspired by Michael Saylor's strategy of buying Bitcoin, REX noted that public companies have begun using convertible bonds to finance their BTC purchases.

Easing Access to Convertible Bonds

BMAX simplifies access to convertible bonds through a single actively managed ETF, focusing on issuers like Strategy₿. It provides a combination of debt stability and equity upside, allowing investors exposure to companies leveraging BTC and the benefits of convertible bonds.

"BMAX is the first ETF providing retail investors and investment advisors access to convertible bonds issued by companies integrating Bitcoin into their financial strategy."Gregory D. King, CEO of REX Financial

Institutional Interest in BTC

This move by REX Shares reinforces the increasing institutional interest in Bitcoin and related products. BMAX provides a regulated and streamlined approach to market engagement, offering indirect exposure to BTC in a more conservative way, valuable for companies seeking to include Bitcoin as a treasury asset.

The launch of BMAX by REX Shares opens a new avenue for investors to access corporate strategies related to Bitcoin through convertible bonds, highlighting the growing interest in cryptocurrencies among institutional investors.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

BioAge Labs Focuses on Metabolic Aging with AI

chest

BioAge Labs is utilizing machine learning to explore metabolic aging and develop treatments for metabolic disorders.

user avatarAyman Ben Youssef

Neumora Therapeutics Targets Brain Diseases with AI

chest

Neumora Therapeutics is developing AI-driven solutions for treating brain diseases, including schizophrenia and Alzheimer's.

user avatarSon Min-ho

Relay Therapeutics Innovates Drug Discovery with AI

chest

Relay Therapeutics is using its AI-powered platform to enhance drug discovery processes in oncology.

user avatarJacob Williams

AI Advances in Biotech: Nobel Prize Winners and Promising Companies

chest

In 2024, the Nobel Prize in Chemistry was awarded to David Baker, Demis Hassabis, and John Jumper for their groundbreaking work in using machine learning to design entirely new proteins, highlighting the growing role of AI in biotech.

user avatarTando Nkube

OBBBA Law Restores R&D Deductions for Biotech Companies

chest

The One Big Beautiful Bill Act restores 100% deduction of R&D expenses for biotech companies, aimed at revitalizing domestic industries and reducing financial pressure.

user avatarZainab Kamara

Launch of OTCfi Token on Olympus Chain

chest

Launch of OTCfi Token on Olympus Chain as part of the partnership between Metavesco and BLAQclouds, aimed at expanding utility in crypto and OTC markets.

user avatarAisha Farooq

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.